Balanced crystalloids vs. 0.9% saline in pediatric diabetic ketoacidosis: a systematic review and meta-analysis of randomized controlled trials - Summary - MDSpire

Balanced crystalloids vs. 0.9% saline in pediatric diabetic ketoacidosis: a systematic review and meta-analysis of randomized controlled trials

  • By

  • Zeid Alkhairi

  • Charlie Kajo

  • Abdolaziz A. Zadeh

  • Dawood Khaja

  • Mohammad Alqaryuti

  • Nada K. Alsaleh

  • Rataj Alibrahim

  • Fahad Almuhannadi

  • Suod Al Hammad

  • Fatima Alqanea

  • Abdullatif Alfehaid

  • July 9, 2026

  • 0 min

Share

Objective:

To evaluate the efficacy and safety of balanced crystalloids versus 0.9% saline for fluid resuscitation in children with diabetic ketoacidosis (DKA).

Approach:
  • Literature Search: Five databases were searched from inception to 27 April 2026 for randomized controlled trials (RCTs) comparing fluid resuscitation strategies in pediatric DKA.
  • Outcomes: Primary outcomes included time to resolution of DKA and incidence of new-onset acute kidney injury (AKI). Secondary outcomes included hospital and PICU length of stay, electrolyte disturbances, and major complications.
  • Statistical Analysis: Random-effects models were used for analysis, with risk of bias assessed using the Cochrane RoB 2 tool and certainty of evidence evaluated using GRADE.
Key Findings:
  • Balanced crystalloids were associated with a modest decrease in time to DKA resolution (MD: −1.60 h, 95% CI: −3.07 to −0.13).
  • Insufficient evidence to determine the effect of fluid choice on new-onset AKI due to substantial statistical uncertainty (RR: 0.55, 95% CI: 0.17–1.82; p = 0.325).
  • Balanced crystalloids were linked to a lower incidence of hypokalemia (RR: 0.66, 95% CI: 0.46–0.93) and hyperchloremia (RR: 0.40, 95% CI: 0.21–0.78).
Interpretation:

Modest benefits in biochemical outcomes were associated with balanced crystalloids, but the small evidence base and low certainty of evidence limit conclusions on clinically important outcomes.

Limitations:
  • Small number of included studies (five RCTs) with a total of 320 patients, which limits the generalizability of the findings.
  • Low certainty of evidence regarding the effects on clinically significant outcomes, which affects the reliability of the conclusions drawn.
Conclusion:

Current evidence is insufficient to support a transition from normal saline to balanced crystalloids as the initial fluid in pediatric DKA. Further large, multicenter RCTs are needed.

Sources:

Original Source(s)

Related Content